The DOI matches its Crossref record; 59 of the 62 references it cites were found in a registry or an index.
Widespread Shortening of 3′UTRs by Alternative Cleavage and Polyadenylation Activates Oncogenes in Cancer Cells
Open accessAbstract
In cancer cells, genetic alterations can activate proto-oncogenes, thereby contributing to tumorigenesis. However, the protein products of oncogenes are sometimes overexpressed without alteration of the proto-oncogene. Helping to explain this phenomenon, we found that when compared to similarly proliferating nontransformed cell lines, cancer cell lines often expressed substantial amounts of mRNA isoforms with shorter 3' untranslated regions (UTRs). These shorter isoforms usually resulted from alternative cleavage and polyadenylation (APA). The APA had functional consequences, with the shorter mRNA isoforms exhibiting increased stability and typically producing ten-fold more protein, in part through the loss of microRNA-mediated repression. Moreover, expression of the shorter mRNA isoform of the proto-oncogene IGF2BP1/IMP-1 led to far more oncogenic transformation than did expression of the full-length, annotated mRNA. The high incidence of APA in cancer cells, with consequent loss of 3'UTR repressive elements, suggests a pervasive role for APA in oncogene activation without genetic alteration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the importance of transcript 3′ UTRs as targets for miRNAs suggests that stem cell quiescence is controlled, at least in part, by mechanisms that alter 3′ UTR length and thus the susceptibility to regulation by miRNAs92–95.”
From Molecular regulation of stem cell quiescence (2013) · cites this paper as [95]
In the citing paper
“Shortening of 3′ UTRs seems to correlate with proliferation in many cell types94, including aberrant proliferation in the case of cancer cells95 or during somatic cell reprogramming99”
From Molecular regulation of stem cell quiescence (2013) · cites this paper as [95]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068
Self-citationThe C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14
Lee, R. C., Feinbaum, R. L., & Ambros, V. (1993) · Cell · doi:10.1016/0092-8674(93)90529-y · Cited by 12,948
Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005) · Cell · doi:10.1016/j.cell.2004.12.035 · Cited by 11,855
Self-citation(2008) · doi:10.1038/nrg2290 · Cited by 5,199
Alternative isoform regulation in human tissue transcriptomes
Wang, E. T., Sandberg, R., Luo, S., Khrebtukova, I., Zhang, L., Mayr, C., Kingsmore, S. F., Schroth, G. P., & Burge, C. B. (2008) · Nature · doi:10.1038/nature07509 · Cited by 5,181
Self-citationCalin, G. A., Dumitru, C. D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., Aldler, H., Rattan, S., Keating, M., Rai, K., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242606799 · Cited by 5,111
Wightman, B., Ha, I., & Ruvkun, G. (1993) · Cell · doi:10.1016/0092-8674(93)90530-4 · Cited by 4,292
MicroRNA Targeting Specificity in Mammals: Determinants beyond Seed Pairing
Grimson, A., Farh, K. K.-H., Johnston, W. K., Garrett-Engele, P., Lim, L. P., & Bartel, D. P. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.06.017 · Cited by 3,766
Self-citationRAS Is Regulated by the let-7 MicroRNA Family
Johnson, S., Großhans, H., Shingara, J., Byrom, M., JARVIS, R., Cheng, A., Labourier, E., Reinert, K. L., Brown, D., & Slack, F. J. (2005) · Cell · doi:10.1016/j.cell.2005.01.014 · Cited by 3,699
A microRNA polycistron as a potential human oncogene
He, L., Thomson, J. M., Hemann, M. T., Hernando, E., Mu, D., Goodson, S. G., Powers, S., Cordon‐Cardo, C., Lowe, S. W., Hannon, G. J., et al. (2005) · Nature · doi:10.1038/nature03552 · Cited by 3,642
Flagged first, then by citations
3 of the 62 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–200 of 999
Burroughs, A. M., Ando, Y., de Hoon, M., Tomaru, Y., Suzuki, H., Hayashizaki, Y., & Daub, C. O. (2011) · RNA Biology · doi:10.4161/rna.8.1.14300 · Cited by 310
Translational Control in CancerPreprint
Robichaud, N., Sonenberg, N., Ruggero, D., & Schneider, R. J. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a032896 · Cited by 313
p53 and MicroRNA-34 Are Suppressors of Canonical Wnt Signaling
Kim, N. H., Kim, N.-G., Kim, N.-G., Lee, I., Choi, H.-S., Li, X.-Y., Kang, S. E., Cha, S. Y., Ryu, J. K., Na, J. M., et al. (2011) · Science Signaling · doi:10.1126/scisignal.2001744 · Cited by 311
Alternative cleavage and polyadenylation: the long and short of it
Tian, B., & Manley, J. L. (2013) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2013.03.005 · Cited by 319
Wu, X., Liu, M., Downie, A. B., Liang, C., Ji, G., Li, Q. Q., & Hunt, A. G. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019732108 · Cited by 300
Erratum: New frontiers in translational control of the cancer genome
Truitt, M., & Ruggero, D. (2017) · Nature reviews. Cancer · doi:10.1038/nrc.2017.30 · Cited by 306
Unravelling the means to an end: RNA polymerase II transcription termination
Kuehner, J. N., Pearson, E. L., & Moore, C. L. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3098 · Cited by 299
Codon Usage and 3′ UTR Length Determine Maternal mRNA Stability in Zebrafish
Mishima, Y., & Tomari, Y. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.02.027 · Cited by 288
Batra, R., Charizanis, K., Manchanda, M., Mohan, A., Li, M., Finn, D. J., Goodwin, M., Zhang, C., Sobczak, K., Thornton, C. A., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.08.027 · Cited by 292
Reyes, A., & Huber, W. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1165 · Cited by 290
Tunable protein synthesis by transcript isoforms in human cells
Floor, S. N., & Doudna, J. A. (2016) · eLife · doi:10.7554/elife.10921 · Cited by 265
Global Analysis of mRNA Isoform Half-Lives Reveals Stabilizing and Destabilizing Elements in Yeast
Geisberg, J. V., Moqtaderi, Z., Fan, X., Ozsolak, F., & Struhl, K. (2014) · Cell · doi:10.1016/j.cell.2013.12.026 · Cited by 270
Fu, Y., Sun, Y., Li, Y., Li, J., Rao, X., Chen, C., & Xu, A. (2011) · Genome Research · doi:10.1101/gr.115295.110 · Cited by 273
Ji, Z., & Tian, B. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008419 · Cited by 264
Li, W., You, B., Hoque, M., Zheng, D., Luo, W., Ji, Z., Park, J. Y., Gunderson, S., Kalsotra, A., Manley, J. L., et al. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005166 · Cited by 270
RNA-binding proteins in Mendelian disease
Castelló, A., Fischer, B., Hentze, M. W., & Preiß, T. (2013) · Trends in Genetics · doi:10.1016/j.tig.2013.01.004 · Cited by 261
Diederichs, S., Bartsch, L., Berkmann, J. C., Fröse, K., Schaule, J., Hoppe, C., Iggena, D., Jazmati, D., Karschnia, P., Linsenmeier, M., et al. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201506055 · Cited by 265
Widespread intronic polyadenylation inactivates tumour suppressor genes in leukaemia
Lee, S., Singh, I., Tisdale, S., Abdel-Wahab, O. I., Leslie, C. S., & Mayr, C. (2018) · Nature · doi:10.1038/s41586-018-0465-8 · Cited by 257
Self-citationSelective autophagy degrades DICER and AGO2 and regulates miRNA activity
Gibbings, D., Mostowy, S., Jay, F., Schwab, Y., Cossart, P., & Voinnet, O. (2012) · Nature Cell Biology · doi:10.1038/ncb2611 · Cited by 257
Targets of miR-200c mediate suppression of cell motility and anoikis resistance
Howe, E. N., Cochrane, D. R., & Richer, J. K. (2011) · Breast Cancer Research · doi:10.1186/bcr2867 · Cited by 248
The end of the message: multiple protein–RNA interactions define the mRNA polyadenylation site
Shi, Y., & Manley, J. L. (2015) · Genes & Development · doi:10.1101/gad.261974.115 · Cited by 249
Distal Alternative Last Exons Localize mRNAs to Neural Projections
Taliaferro, J. M., Vidaki, M., Oliveira, R., Olson, S., Zhan, L., Saxena, T., Wang, E. T., Graveley, B. R., Gertler, F. B., Swanson, M. S., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.01.020 · Cited by 254
Alternative mRNA splicing in cancer immunotherapy
Frankiw, L., Baltimore, D., & Li, G. (2019) · Nature reviews. Immunology · doi:10.1038/s41577-019-0195-7 · Cited by 253
Entering the era of single-cell transcriptomics in biology and medicine
Sandberg, R. (2013) · Nature Methods · doi:10.1038/nmeth.2764 · Cited by 252
Dissecting the expression landscape of RNA-binding proteins in human cancers
Kechavarzi, B., & Janga, S. C. (2014) · Genome biology · doi:10.1186/gb-2014-15-1-r14 · Cited by 243
Signals for pre‐mRNA cleavage and polyadenylation
Tian, B., & Graber, J. H. (2011) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.116 · Cited by 250
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons
Liu, E. Y., Russ, J., Cali, C. P., Phan, J. M., Amlie-Wolf, A., & Lee, E. B. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.04.003 · Cited by 231
“0 Ran et al., 2013 Addgene #62988 pMSCV-PIG Mayr and Bartel, 2009 Addgene #21654 Software and Algorithms R Bioconductor R Core Team, 2015 http://www.R-project.org/ GraphPad Prism GraphPad DESeq2 Love et al., 2014 https://github.com/mikelove/DESeq2 rMATS Shen et al., 2014…”
BackgroundMethodGlobal Patterns of Tissue-Specific Alternative Polyadenylation in Drosophila
Smibert, P., Miura, P., Westholm, J. O., Shenker, S., May, G. E., Duff, M. O., Zhang, D., Eads, B. D., Carlson, J., Brown, J. B., et al. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.01.001 · Cited by 226
The Spen Family Protein FPA Controls Alternative Cleavage and Polyadenylation of RNA
Hornyik, C., Terzi, L. C., & Simpson, G. G. (2010) · Developmental Cell · doi:10.1016/j.devcel.2009.12.009 · Cited by 229
Dysregulation of the basal RNA polymerase transcription apparatus in cancer
Bywater, M. J., Pearson, R. B., McArthur, G. A., & Hannan, R. D. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3496 · Cited by 224
Competing endogenous RNA networks: tying the essential knots for cancer biology and therapeutics
Sánchez-Mejías, A., & Tay, Y. (2015) · Journal of Hematology & Oncology · doi:10.1186/s13045-015-0129-1 · Cited by 222
Gruber, A. J., Schmidt, R., Gruber, A. J., Martin, G., Ghosh, S., Belmadani, M., Keller, W., & Zavolan, M. (2016) · Genome Research · doi:10.1101/gr.202432.115 · Cited by 213
RHOA G17V Induces T Follicular Helper Cell Specification and Promotes Lymphomagenesis
Cortés, J. R., Ambesi‐Impiombato, A., Couronné, L., Quinn, S. A., Kim, C. S., Almeida, A. C. D. S., West, Z., Belver, L., Martin, M. S., Scourzic, L., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.01.001 · Cited by 219
Hodson, D. J., Janas, M. L., Galloway, A., Bell, S. E., Andrews, S., Li, C. M., Pannell, R., Siebel, C. W., MacDonald, H. R., Keersmaecker, K. D., et al. (2010) · Nature Immunology · doi:10.1038/ni.1901 · Cited by 219
Petz, M., Them, N. C. C., Huber, H., Beug, H., & Mikulits, W. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr717 · Cited by 214
Spies, N., Burge, C. B., & Bartel, D. P. (2013) · Genome Research · doi:10.1101/gr.156919.113 · Cited by 217
Self-citationAttenuation of miR-126 Activity Expands HSC In Vivo without Exhaustion
Lechman, E. R., Gentner, B., van Galen, P., Giustacchini, A., Saini, M., Boccalatte, F. E., Hiramatsu, H., Restuccia, U., Bachi, A., Voisin, V., et al. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.09.001 · Cited by 208
Alternative polyadenylation: New insights from global analyses
Shi, Y. (2012) · RNA · doi:10.1261/rna.035899.112 · Cited by 212
mRNA transport & local translation in neurons
Glock, C., Heumüller, M., & Schuman, E. M. (2017) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2017.05.005 · Cited by 217
Jima, D. D., Zhang, J., Jacobs, C. L., Richards, K. L., Dunphy, C. H., Choi, W. W. L., Au, W. Y., Srivastava, G., Czader, M., Rizzieri, D. A., et al. (2010) · Blood · doi:10.1182/blood-2010-05-285403 · Cited by 209
The roles of RNA processing in translating genotype to phenotype
Manning, K. S., & Cooper, T. A. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.139 · Cited by 212
Genetic variants in mRNA untranslated regions
Steri, M., Idda, M. L., Whalen, M. B., & Orrù, V. (2018) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1474 · Cited by 209
Leskelä, S., Leandro-Garcia, L. J., Mendiola, M., Barriuso, J., Inglada‐Pérez, L., Muñoz, I. G., Martínez–Delgado, B., Redondo, A., de Santiago, J., Robledo, M., et al. (2010) · Endocrine Related Cancer · doi:10.1677/erc-10-0148 · Cited by 202
Global 3′ UTR shortening has a limited effect on protein abundance in proliferating T cells
Gruber, A. J., Martin, G., Müller, P., Schmidt, A., Gruber, A. J., Gumienny, R., Mittal, N., Jayachandran, R., Pieters, J., Keller, W., et al. (2014) · Nature Communications · doi:10.1038/ncomms6465 · Cited by 206
Uzonyi, A., Dierks, D., Nir, R., Kwon, O. S., Toth, U., Barbosa, I., Burel, C., Brandis, A. S., Rossmanith, W., Hir, H. L., et al. (2023) · Molecular Cell · doi:10.1016/j.molcel.2022.12.026 · Cited by 209
Evaluation and comparison of computational tools for RNA-seq isoform quantification
Zhang, C., Zhang, B., Lin, L., & Zhao, S. (2017) · BMC Genomics · doi:10.1186/s12864-017-4002-1 · Cited by 200
Translational control of stem cell function
Saba, J. A., Liakath‐Ali, K., Green, R., & Watt, F. M. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00386-2 · Cited by 205
Principles of miRNA–mRNA interactions: beyond sequence complementarity
Afonso-Grunz, F., & Müller, S. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1922-2 · Cited by 196
The Emerging Function and Mechanism of ceRNAs in Cancer
Wang, Y., Hou, J., He, D., Sun, M., Zhang, P., Yu, Y., & Chen, Y. (2016) · Trends in Genetics · doi:10.1016/j.tig.2016.02.001 · Cited by 187
Heterogeneous Responses of Hematopoietic Stem Cells to Inflammatory Stimuli Are Altered with Age
Mann, M., Mehta, A., de Boer, C. G., Kowalczyk, M. S., Lee, K., Haldeman, P., Rogel, N., Knecht, A. R., Farouq, D., Regev, A., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.11.056 · Cited by 188
Brümmer, A., & Hausser, J. (2014) · BioEssays · doi:10.1002/bies.201300104 · Cited by 170
MicroRNA-1 is a candidate tumor suppressor and prognostic marker in human prostate cancer
Hudson, R. S., Yi, M., Esposito, D., Watkins, S. K., Hurwitz, A. A., Yfantis, H. G., Lee, D. H., Borin, J. F., Naslund, M. J., Alexander, R. B., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr1222 · Cited by 186
Liu, Y., Hu, W., Murakawa, Y., Yin, J., Wang, G., Landthaler, M., & Yan, J. (2013) · Scientific Reports · doi:10.1038/srep02054 · Cited by 188
Comprehensive Characterization of Alternative Polyadenylation in Human Cancer
Xiang, Y., Ye, Y., Lou, Y., Yang, Y., Cai, C. C., Zhang, Z., Mills, T., Chen, N., Kim, Y.-J., Ozguc, F. M., et al. (2017) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djx223 · Cited by 183
Inhibition of YTHDF2 triggers proteotoxic cell death in MYC-driven breast cancer
Einstein, J. M., Perelis, M., Chaim, I. A., Meena, J. K., Nussbacher, J. K., Tankka, A. T., Yee, B. A., Li, H., Madrigal, A. A., Neill, N. J., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.06.014 · Cited by 187
Genome organization around nuclear speckles drives mRNA splicing efficiency
Bhat, P., Chow, A. Y., Emert, B. L., Ettlin, O., Quinodoz, S. A., Strehle, M. M., Takei, Y., Burr, A., Goronzy, I. N., Chen, A. W., et al. (2024) · Nature · doi:10.1038/s41586-024-07429-6 · Cited by 190
Smith, K. M., Guerau‐de‐Arellano, M., Costinean, S., Williams, J. L., Bottoni, A., Cox, G. M., Satoskar, A. R., Croce, C. M., Racke, M. K., Lovett‐Racke, A. E., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103171 · Cited by 183
Targeting mRNA processing as an anticancer strategy
Desterro, J. M. P., Bak‐Gordon, P., & Carmo‐Fonseca, M. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0042-3 · Cited by 181
RNA-binding activity of TRIM25 is mediated by its PRY/SPRY domain and is required for ubiquitination
Choudhury, N. R., Heikel, G., Trubitsyna, M., Kubík, P., Nowak, J. S., Webb, S., Granneman, S., Spanos, C., Rappsilber, J., Castelló, A., et al. (2017) · BMC Biology · doi:10.1186/s12915-017-0444-9 · Cited by 187
3′ UTR shortening represses tumor-suppressor genes in trans by disrupting ceRNA crosstalk
Park, H. J., Ji, P., Kim, S., Xia, Z., Rodriguez, B. A. T., Li, L., Su, J., Chen, K., Masamha, C. P., Baillat, D., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0118-8 · Cited by 178
Loher, P., Telonis, A. G., & Rigoutsos, I. (2017) · Scientific Reports · doi:10.1038/srep41184 · Cited by 176
Multiple mechanisms disrupt the let-7 microRNA family in neuroblastoma
Powers, J. T., Tsanov, K. M., Pearson, D. S., Roels, F., Spina, C. S., Ebright, R. Y., Seligson, M. T., de Soysa, Y., Cahan, P., Theißen, J., et al. (2016) · Nature · doi:10.1038/nature18632 · Cited by 175
Cleavage and polyadenylation: Ending the message expands gene regulation
Neve, J., Patel, R. J., Wang, Z., Louey, A., & Furger, A. (2017) · RNA Biology · doi:10.1080/15476286.2017.1306171 · Cited by 185
Roles for transcript leaders in translation and mRNA decay revealed by transcript leader sequencingPreprint
Arribere, J. A., & Gilbert, W. V. (2013) · Genome Research · doi:10.1101/gr.150342.112 · Cited by 175
microRNAs and RNA-binding proteins
Ciafrè, S. A., & Galardi, S. (2013) · RNA Biology · doi:10.4161/rna.24641 · Cited by 179
Davidson, L., Muniz, L., & West, S. (2014) · Genes & Development · doi:10.1101/gad.231274.113 · Cited by 183
Poly(A) binding protein nuclear 1 levels affect alternative polyadenylation
de Klerk, E., Venema, A., Anvar, S. Y., Goeman, J. J., Hu, O., Trollet, C., Dickson, G., den Dunnen, J. T., van der Maarel, S. M., Raz, V., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks655 · Cited by 166
MicroRNAs as gatekeepers of apoptosis
Subramanian, S., & Steer, C. J. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22066 · Cited by 170
Beaudoin, J.-D., & Perreault, J. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt265 · Cited by 174
Translational control by 3'-UTR-binding proteins
Szostak, E., & Gebauer, F. (2012) · Briefings in Functional Genomics · doi:10.1093/bfgp/els056 · Cited by 169
Mechanisms, Hallmarks, and Implications of Stem Cell Quiescence
Cho, I., Lui, P. P., Obajdin, J., Riccio, F., Stroukov, W., Willis, T. L., Spagnoli, F. M., & Watt, F. M. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.05.012 · Cited by 171
Fip1 regulates mRNA alternative polyadenylation to promote stem cell self‐renewal
Lackford, B. L., Yao, C., Charles, G. M., Weng, L., Zheng, X., Choi, E., Xie, X. S., Wan, J., Xing, Y., Freudenberg, J., et al. (2014) · The EMBO Journal · doi:10.1002/embj.201386537 · Cited by 165
The RNA-binding protein repertoire of Arabidopsis thaliana
Marondedze, C., Thomas, L. A., Serrano, N., Lilley, K. S., & Gehring, C. (2016) · Scientific Reports · doi:10.1038/srep29766 · Cited by 165
CPEB1 coordinates alternative 3′-UTR formation with translational regulation
Bava, F.-A., Eliscovich, C., Ferreira, P. G., Miñana, B., Ben-Dov, C., Guigó, R., Valcárcel, J., & Méndez, R. (2013) · Nature · doi:10.1038/nature11901 · Cited by 167
Li, Z., Huang, H., Chen, P., He, M., Li, Y., Arnovitz, S., Jiang, X., He, C., Hyjek, E. M., Zhang, J., et al. (2012) · Nature Communications · doi:10.1038/ncomms1681 · Cited by 167
Modelling mammalian cellular quiescence
Yao, G. (2014) · Interface Focus · doi:10.1098/rsfs.2013.0074 · Cited by 180
Stable RNA interference rules for silencing
Fellmann, C., & Lowe, S. W. (2013) · Nature Cell Biology · doi:10.1038/ncb2895 · Cited by 170
Tang, W., Zhou, M., Dorsey, T. H., Prieto, D. A., Wang, X. W., Ruppin, E., Veenstra, T. D., & Ambs, S. (2018) · Genome Medicine · doi:10.1186/s13073-018-0602-x · Cited by 162
High-Throughput Analysis Reveals Rules for Target RNA Binding and Cleavage by AGO2
Becker, W. R., Ober-Reynolds, B., Jouravleva, K., Jolly, S. M., Zamore, P. D., & Greenleaf, W. J. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.06.012 · Cited by 161
An extensive program of periodic alternative splicing linked to cell cycle progression
Dominguez, D., Tsai, Y., Weatheritt, R. J., Wang, Y., Blencowe, B. J., & Wang, Z. (2016) · eLife · doi:10.7554/elife.10288 · Cited by 167
Widespread intronic polyadenylation diversifies immune cell transcriptomes
Singh, I., Lee, S., Sperling, A. S., Samur, M., Tai, Y., Fulciniti, M., Munshi, N. C., Mayr, C., & Leslie, C. S. (2018) · Nature Communications · doi:10.1038/s41467-018-04112-z · Cited by 160
Self-citationDirect sequencing of Arabidopsis thaliana RNA reveals patterns of cleavage and polyadenylation
Sherstnev, A., Duc, C., Cole, C., Zacharaki, V., Hornyik, C., Ozsolak, F., Milos, P. M., Barton, G. J., & Simpson, G. G. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2345 · Cited by 157
Post-transcriptional control during chronic inflammation and cancer: a focus on AU-rich elements
Khabar, K. S. A. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0383-x · Cited by 157
Singh, P., Alley, T. L., Wright, S., Kamdar, S. J., Schott, W. H., Wilpan, R. Y., Mills, K. D., & Graber, J. H. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2236 · Cited by 160
Architecture of eukaryotic mRNA 3′-end processing machinery
Casañal, A., Kumar, A., Hill, C. H., Easter, A., Emsley, P., Degliesposti, G., Gordiyenko, Y., Santhanam, B., Wolf, J., Wiederhold, K., et al. (2017) · Science · doi:10.1126/science.aao6535 · Cited by 157
van den Hoogenhof (2016) · doi:10.1161/circresaha.115.307872 · Cited by 134
E2F mediates enhanced alternative polyadenylation in proliferation
Elkon, R., Drost, J., van Haaften, G. W., Jenal, M., Schrier, M., Vrielink, J. A. F. O., & Agami, R. (2012) · Genome biology · doi:10.1186/gb-2012-13-7-r59 · Cited by 158
The genetic and biochemical determinants of mRNA degradation rates in mammals
Agarwal, V., & Kelley, D. R. (2022) · Genome Biology · doi:10.1186/s13059-022-02811-x · Cited by 155
Pumilio facilitates miRNA regulation of the E2F3 oncogenePreprint
Miles, W. O., Tschöp, K., Herr, A., Ji, J., & Dyson, N. J. (2012) · Genes & Development · doi:10.1101/gad.182568.111 · Cited by 154
Competing endogenous RNA interplay in cancer: mechanism, methodology, and perspectives
Cheng, D.-L., Xiang, Y., Ji, L.-J., & Lu, X. (2015) · Tumor Biology · doi:10.1007/s13277-015-3093-z · Cited by 154
Alternative polyadenylation: methods, mechanism, function, and role in cancer
Zhang, Y., Liu, L., Qiu, Q., Zhou, Q. H., Ding, J., Lü, Y., & Liu, P. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01852-7 · Cited by 158
Deterministic and Stochastic Allele Specific Gene Expression in Single Mouse Blastomeres
Tang, F., Bárbácioru, C., Nordman, E., Bao, S., Lee, C. G. L., Wang, X., Tuch, B. B., Heard, É., Lao, K., & Surani, M. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021208 · Cited by 153
Alternative Polyadenylation Mediates MicroRNA Regulation of Muscle Stem Cell Function
Boutet, S. C., Cheung, T. H., Quach, N. L., Liu, L., Prescott, S. L., Edalati, A., Iori, K., & Rando, T. A. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.01.017 · Cited by 150
Key contribution of CPEB4-mediated translational control to cancer progression
Zapater, E. O., Pineda, D., Martínez‐Bosch, N., Fernández‐Miranda, G., Iglesias, M., Alameda, F., Moreno, M., Eliscovich, C., Eyras, E., Real, F. X., et al. (2011) · Nature Medicine · doi:10.1038/nm.2540 · Cited by 149
Pre‐mRNA 3′‐end processing complex assembly and function
Chan, S., Choi, E., & Shi, Y. (2011) · WIREs RNA · doi:10.1002/wrna.54 · Cited by 147
Nudt21 Controls Cell Fate by Connecting Alternative Polyadenylation to Chromatin Signaling
Brumbaugh, J., Stefano, B. D., Wang, X., Borkent, M., Forouzmand, E., Clowers, K. J., Ji, F., Schwarz, B. A., Kalocsay, M., Elledge, S. J., et al. (2017) · Cell · doi:10.1016/j.cell.2017.11.023 · Cited by 148
Gerstberger, S. C., Hafner, M., Ascano, M., & Tuschl, T. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-1221-6_1 · Cited by 154
Alternative mRNA polyadenylation in eukaryotes: an effective regulator of gene expression
Lutz, C. S., & Moreira, A. (2010) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.47 · Cited by 143
Shi, L., Zhang, Z., Yu, A. M., Wang, W., Wei, Z., Akhter, E., Maurer, K., Costa‐Reis, P., Song, L., Petri, M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093846 · Cited by 142
An in-depth map of polyadenylation sites in cancer
Lin, Y., Li, Z., Ozsolak, F., Kim, S. W., Arango-Argoty, G., Liu, T. T., Tenenbaum, S. A., Bailey, T. L., Monaghan, A. P., Milos, P. M., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks637 · Cited by 142
Metadata
- Authors
- Mayr, C., & Bartel, D. P.
- Affiliations
- Howard Hughes Medical Institute (US)
- Memorial Sloan Kettering Cancer Center (US)
- Corresponding author
- Mayr, Christine
- Bartel, David P.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2009-08
- Volume
- 138
- Issue
- 4
- Pages
- 673-684
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC2819821
- OpenAlex
- W1542927170
- Cited by
- 1,613
- References
- 62
- Citations by year
- 2026: 57 · 2025: 60 · 2024: 87 · 2023: 98 · 2022: 99 · 2021: 118 · 2020: 96 · 2019: 95 · 2018: 100 · 2017: 100 · 2016: 87 · 2015: 86 · 2014: 116 · 2013: 129 · 2012: 114
- FWCI
- 37.94
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-sa)
- PMC
- Funders
- Howard Hughes Medical Institute
- National Cancer Institute (P30CA008748)
- National Institute of General Medical Sciences (R01GM067031)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK068348)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Keywords
- alternative polyadenylation, mRNA isoforms, oncogene activation, proto-oncogenes, mRNA stability, oncogenic transformation, cancer cells
- MeSH terms
- Proto-Oncogene Mas, Cell Transformation, Neoplastic, Humans, Mutation, Oncogenes, Gene Expression Regulation, Neoplastic, S Phase, Cyclins, RNA-Binding Proteins, Alternative Splicing, 3' Untranslated Regions, RNA Stability, Polyadenylation, Cell Line, Tumor, Cyclin D2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review